序号 |
标题 |
次数 |
作者 |
发布时间 |
72676 |
Azido-PEG4-Val-Ala-PAB的介绍 |
77 |
zyl |
2024-12-19 |
72677 |
2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate,ADC定制 |
63 |
wyh |
2024-12-19 |
72678 |
OH-Glu-VC-PAB-MMAE, ADC试剂 |
128 |
kx |
2024-12-19 |
72679 |
cas:663599-10-8,2,5-dioxopyrrolidin-1-yl 4-((3-(dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoate,ADC定制 |
71 |
wyh |
2024-12-19 |
72680 |
GGVA-PAB-PNU, ADC试剂 |
110 |
kx |
2024-12-19 |
72681 |
132178-37-1,4-戊炔酸琥珀亚胺酯,ADC定制 |
175 |
wyh |
2024-12-19 |
72682 |
cas:863971-53-3 Fmoc-Val-Cit-PAB-PNP |
72 |
zyl |
2024-12-19 |
72683 |
N3-PEG4-vc-PAB-Doxorubicin,药物递送系统的一部分 |
117 |
WYQ |
2024-12-19 |
72684 |
cas:55750‐61‐3,N-SMP,马来酰亚胺基乙酸琥珀酰亚胺酯,ADC定制 |
94 |
wyh |
2024-12-19 |
72685 |
MC-PEG4-EDA-PNU, ADC试剂 |
123 |
kx |
2024-12-19 |
72686 |
cas:2055024-54-7 Boc-PEG4-Val-Cit-PAB-OH |
114 |
zyl |
2024-12-19 |
72687 |
Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB-PNP(CAS: 2055042-82-3) |
100 |
WYQ |
2024-12-19 |
72688 |
Mal-amido-PEG8-val-gly-PAB-OH(CAS: 2353409-52-4) |
105 |
WYQ |
2024-12-19 |
72689 |
cas:160854-54-6,4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene,ADC定制 |
86 |
wyh |
2024-12-19 |
72690 |
cas:2504147-59-3 MC (C5)-Val-Cit |
124 |
zyl |
2024-12-19 |
72691 |
Boc-PEG4-Val-Ala-PAB,可降解的ADC连接体 |
135 |
WYQ |
2024-12-19 |
72692 |
cas:2058075-34-4,DGN549-C , ADC试剂 |
72 |
kx |
2024-12-19 |
72693 |
CAS: 1639939-40-4,Mal-Val-Ala-PAB-PNP,马来酰亚胺-VAL-ALA-PAB-PNP |
122 |
WYQ |
2024-12-19 |
72694 |
Fmoc-VC-PAB-Duocarmycin SA, ADC试剂 |
95 |
kx |
2024-12-19 |
72695 |
Mal-PEG4-Val-Ala-PAB,可降解的ADC(抗体偶联药物)连接子 |
153 |
WYQ |
2024-12-19 |
72696 |
Mal-PEG1-Val-Cit-OH的介绍 |
123 |
zyl |
2024-12-19 |
72697 |
MC-vc-PAB-Monomethyl dolastatin10, ADC试剂 |
83 |
kx |
2024-12-19 |
72698 |
CAS: 1870916-87-2,Mal-Val-Ala-PAB,马来酰亚胺-缬氨酸-丙氨酸-对氨基苯甲酸 |
89 |
WYQ |
2024-12-19 |
72699 |
cas:2395887-69-9 Mal-PEG2-Val-Cit-PAB-PNP |
84 |
zyl |
2024-12-19 |
72700 |
SuO-Val-Cit-PAB-MMAE, ADC试剂 |
74 |
kx |
2024-12-19 |
72701 |
Mal-PEG4-Val-Ala-PAB-PNP的介绍 |
87 |
zyl |
2024-12-19 |
72702 |
CAS: 2348405-93-4,DBCO-PEG4-Val-Ala-PAB-PNP |
63 |
WYQ |
2024-12-19 |
72703 |
CAS: 2348405-92-3,DBCO-PEG4-Val-Ala-PAB |
76 |
WYQ |
2024-12-19 |
72704 |
cas:2112738-13-1 Mal-amido-PEG2-Val-Cit-PAB-PNP |
77 |
zyl |
2024-12-19 |
72705 |
Azido-PEG4-Val-Ala-PAB,分子式:C29H48N8O9 |
67 |
WYQ |
2024-12-19 |
72706 |
cas:2055896-86-9,MC-Val-Cit-PAB-tubulysin5a , ADC试剂 |
83 |
kx |
2024-12-19 |
72707 |
Azido-PEG8-Val-Cit-PAB-PNP |
62 |
zyl |
2024-12-19 |
72708 |
cas:2055896-83-6,MC-Val-Cit-PAB-carfilzomib , ADC试剂 |
106 |
kx |
2024-12-19 |
72709 |
MAL-di-EG-Val-Cit-PAB-MMAF, ADC试剂 |
76 |
kx |
2024-12-19 |
72710 |
cas:2353409-45-5 endo BCN-PEG3-VC-PFP Ester |
87 |
zyl |
2024-12-19 |
72711 |
Hydrazone-doxorubicin, ADC试剂 |
156 |
kx |
2024-12-19 |
72712 |
DBCO-C4-Val-Cit-PABC-PNP |
64 |
zyl |
2024-12-19 |
72713 |
cas:644981-35-1 Val-Cit-PAB-MMAE |
76 |
zyl |
2024-12-19 |
72714 |
cas:170908-81-3,DOTA-NHS ester ,1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 1-(2,5-二氧代-1-吡咯烷基)酯 |
69 |
kx |
2024-12-19 |
72715 |
endo-BCN-PEG4-Val-Cit-PAB-MMAE的介绍 |
75 |
zyl |
2024-12-19 |
72716 |
cas:2259318-50-6,MA-PEG4-VA-PBD , ADC试剂 |
91 |
kx |
2024-12-19 |
72717 |
CAS: 2259318-55-1 - DBCO-(PEG2-VC-PAB-MMAE)2 |
59 |
WYQ |
2024-12-19 |
72718 |
CAS: 2768446-73-5,DBCO-Val-Cit-PAB-MMAE |
72 |
WYQ |
2024-12-19 |
72719 |
MC-vc-PAB-C6-a-amanitin, ADC试剂 |
62 |
kx |
2024-12-19 |
72720 |
cas:663598-98-9,2,5-dioxopyrrolidin-1-yl 4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoate,ADC定制 |
78 |
wyh |
2024-12-19 |